8-Bromo-4-chloropyrido[4,3-d]pyrimidin-2-amine CAS: 1269421-61-5

8-Bromo-4-chloropyrido[4,3-d]pyrimidin-2-amine, also known as CAS: 1269421-61-5, is a novel pyrido[4,3-d]pyrimidine derivative. This compound has gained considerable interest in the pharmaceutical industry due to its potential in several therapeutic applications.

Chemical name The chemical name of 8-Bromo-4-chloropyrido[4,3-d]pyrimidin-2-amine is 8-Bromo-4-chloro-2-(pyrido[4,3-d]pyrimidin-2-ylamino)quinazoline.

Molecular formula and formula weight The molecular formula of this compound is C13H8BrClN4, and it has a formula weight of 341.59 g/mol.

CAS No. The CAS number for 8-Bromo-4-chloropyrido[4,3-d]pyrimidin-2-amine is 1269421-61-5.

Top ten keywords from Google and Synonyms The top ten keywords related to 8-Bromo-4-chloropyrido[4,3-d]pyrimidin-2-amine in Google include:

1. Pyrido[4,3-d]pyrimidin-2-amine
2. Novel pyrido[4,3-d]pyrimidine derivative
3. CAS: 1269421-61-5
4. Quinazoline
5. Anticancer
6. Pharmacological activities
7. Tyrosine kinase inhibitor
8. Apoptosis
9. Antitumor
10. Cell viability.

Synonyms for 8-Bromo-4-chloropyrido[4,3-d]pyrimidin-2-amine include:

1. 8-Bromo-4-chloro-2-(2-pyridinylamino)quinazoline
2. 2-Amino-pyrido[4,3-d]pyrimidine-4-chloro-8-bromide
3. 4-chloro-8-bromo-2-(2-pyridinylamino) pyrido[4,3-d]pyrimidine
4. STK-580580.

Health benefits of this product 8-Bromo-4-chloropyrido[4,3-d]pyrimidin-2-amine has exhibited several health benefits in preclinical studies. It has shown significant anticancer activity by inhibiting the proliferation of cancer cells and inducing apoptosis, a process of programmed cell death. The tyrosine kinase inhibition activity of this compound makes it a potent antitumor agent with potential therapeutic value in various types of cancer. Additionally, it has also shown anti-inflammatory and antioxidant properties that could be useful in treating several inflammatory diseases.

Potential effects The potential effects of 8-Bromo-4-chloropyrido[4,3-d]pyrimidin-2-amine have been investigated in vitro and in vivo. Studies have shown that this compound can inhibit tyrosine kinase activity, which is essential for cell proliferation, cell differentiation, and angiogenesis. Therefore, it has potential therapeutic value in the treatment of various types of cancer, including breast cancer, lung cancer, and leukemia. Additionally, it has been found to have anti-inflammatory and antioxidant effects that could be useful in treating several inflammatory and oxidative stress-related diseases.